Research output per year
Research output per year
Personal profile
Overview
Reader in Synthetic Biology and Quantitative Genomics, Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health at Manchester University. Principle Investigator at the Manchester Institute of Biotechnology. Philip is also Business Engagement Lead for the Division of Evolution and Genomic Sciences, Postgraduate Research Tutor and Biomed Sciences Academic Tutor and Academic Advisor.
Biography
August 2007 to Present. Reader in Synthetic Biology and Quantitative Genomics, Faculty of Biology, Medicine and Health, Manchester University, and Principle Investigator at the Manchester Institute of Biotechnology.
2018 to present. Honorary Professor, Department of Bioengineering, University California, Berkeley, CA, USA.
2013 to 2017. Honorary Professor, Department of Biomedical Engineering, University of Irvine, California, USA.
2006 to 2007. Visiting Professor of Applied Molecular Biology and Biochemistry, Institut für Spektrochemie und Angewandte Spektroskopie, Dortmund Institute of Technology, Germany.
June 2004 to July 2007 Senior Lecturer in Genomics and Principal Investigator. Centre for Integrated Genomic Medical Research, & Manchester Interdisciplinary Biocentre, University of Manchester.
2002 to 2004. Senior Lecturer in Genomics. Centre for Integrated Genomic Medical Research, Medical School, University of Manchester.
1998 to 2002. Head of Gene Arrays and Technologies. Functional Genomics Unit, Divisions of Oncology and Infectious Diseases. Children’s Hospital, University of Zürich, Switzerland.
1997 to 1998. Post-doctoral Fellow. .Department of Biochemistry, University of Oxford.
1995 to 1997. Post-doctoral Fellow. The human gene mapping project, The Wellcome Trust Centre for Human Genetics, University of Oxford.
1991 to 1995. Senior Scientist, Departments of Oncology and Haematology, Department of Clinical Chemistry, Children's Hospital, Birmingham.
Research interests
Philip Day is Reader in Quantitative Analytical Genomics at Manchester University, Director of the Quantitative Molecular Medicine Group and Principle Investigator at the Manchester Institute of Biotechnology, and a member of the Centre for Epidemiology and CIGMR, at the Medical Faculty. He currently is developing synthetic biology and chemical biology approaches to directed evolution of novel proteins and aptamers for biomedical applications. These are used in combination with expertise for building integrated pathogenesis models of CML. Other closely related studies concern the enhanced uptake of anti-cancer drugs through membrane associated transporters, and Philip maintains an academic interest in the biological significance of heterogeneity.
Teaching
PGR Tutor
Biomedical Sciences Tutor
Module co-ordinator MRes Translational Medicine
Memberships of committees and professional bodies
Chartered Scientist, 2016
Chartered Chemist, 2016
Fellow of the Royal Society of Chemistry, 2004
Fellow of the Royal Society of Biology, 2008
Senior Management Team, EGS
Business Engagement Champion, FMHS
Methodological knowledge
qPCR
molecular biology
Assay development
sample preparation and handling
Single cell analysis, homogeneous sample handling
Aptamer development
Systems biology/medicine
Chemical biology
Synthetic biology
Qualifications
Chartered Scientist, 2016
Chartered Chemist, 2016
Fellow of the Society of Biology, 2008
Fellow of the Royal Society of Chemistry, 2004
PhD, Wolfson Research Laboratories, Faculty of Sciences, Univ of Birmingham
MPhil, Wolfson Resarch Laboratories, Faculty of Medicine, Univ of Birmingham
BSc (Hons) Biological Sciences, University of Lancaster.
Supervision information
2020
Analysis of microbial properties using flow cytometry
Author: Jindal, Srijan, 5 Jun 2020
Supervisor: Day, P. (Supervisor)
UoM administered thesis: Phd
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Honorary Professor, UC Berkeley
1 Apr 2019 → …
Visiting Professor, UCI, Biomedical Engineering
2013 → 2017
Areas of expertise
- QD Chemistry
- RZ Other systems of medicine
- TP Chemical technology
Research Beacons, Institutes and Platforms
- Advanced materials
- Cancer
- Biotechnology
- Digital Futures
- Dementia@Manchester
- Manchester Precision Medicine Institute
- Christabel Pankhurst Institute
- Manchester Institute of Biotechnology
Fingerprint
Dive into the research topics where Philip Day is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Viral Involvement in Alzheimer’s Disease
Sait, A., Angeli, C., Doig, A. J. & Day, P. J. R., 9 Mar 2021, In: ACS Chemical Neuroscience.Research output: Contribution to journal › Article › peer-review
Open Access -
MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies
Parkes, J., Thoma, A., Lightfoot, A. P., Day, P., Chinoy, H. & Lamb, J., 19 Mar 2020, (Accepted/In press) In: BMC Rheumatology.Research output: Contribution to journal › Article › peer-review
-
Ultrasensitive and rapid detection of malaria using graphene-enhanced surface plasmon resonance
Wu, F., Singh, J., Thomas, P. A., Ge, Q., Kravets, V. G., Day, P. J. & Grigorenko, A. N., 1 Oct 2020, In: 2D Materials. 7, 4Research output: Contribution to journal › Article › peer-review
Open Access -
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
Zhang, S., Sakuma, M., Deora, G. S., Levy, C., Klausing, A., Breda, C., Read, K. D., Ross, B. P., Wright Muelas, M., Day, P., O'Hagan, S., Kell, D., Schwarcz, R., Leys, D., Heyes, D., Giorgini, F. & Scrutton, N., 2019, In: Communications Biology.Research output: Contribution to journal › Article › peer-review
Open Access -
GeneORator: An Effective Strategy for Navigating Protein Sequence Space More Efficiently through Boolean OR-Type DNA Libraries
Currin, A., Kwok, J., Sadler, J. C., Bell, E. L., Swainston, N., Ababi, M., Day, P., Turner, N. J. & Kell, D. B., 21 Jun 2019, In: ACS Synthetic Biology. 8, 6, p. 1371-1378Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Supplementary material from "Computing exponentially faster: implementing a non-deterministic universal Turing machine using DNA"
Currin, A. (Contributor), Korovin, K. (Contributor), Ababi, M. (Contributor), Roper, K. (Contributor), Kell, D. (Contributor), Day, P. (Contributor) & King, R. (Contributor), figshare , 15 Feb 2017
DOI: 10.6084/m9.figshare.c.3691882.v1, https://figshare.com/collections/Supplementary_material_from_Computing_exponentially_faster_implementing_a_non-deterministic_universal_Turing_machine_using_DNA_/3691882/1
Dataset
-
Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies
Parkes, J. (Contributor), Rothwell, S. (Contributor), Day, P. (Contributor), McHugh, N. J. (Contributor), Betteridge, Z. E. (Contributor), Cooper, R. G. (Contributor), Ollier, W. (Contributor), Chinoy, H. (Contributor) & Lamb, J. (Contributor), figshare , 7 Jul 2016
DOI: 10.6084/m9.figshare.c.3609506.v1, https://figshare.com/collections/Systematic_protein-protein_interaction_and_pathway_analyses_in_the_idiopathic_inflammatory_myopathies/3609506/1
Dataset